key: cord-0015031-uh9zki7q
authors: Furmanik, Malgorzata; van Gorp, Rick; Whitehead, Meredith; Ahmad, Sadia; Bordoloi, Jayanta; Kapustin, Alexander; Schurgers, Leon J.; Shanahan, Catherine M.
title: Endoplasmic Reticulum Stress Mediates Vascular Smooth Muscle Cell Calcification via Increased Release of Grp78 (Glucose-Regulated Protein, 78 kDa)-Loaded Extracellular Vesicles
date: 2020-12-10
journal: Arterioscler Thromb Vasc Biol
DOI: 10.1161/atvbaha.120.315506
sha: c0158f03420cd73041408724d78ed9c44330497a
doc_id: 15031
cord_uid: uh9zki7q

Vascular calcification is common among aging populations and mediated by vascular smooth muscle cells (VSMCs). The endoplasmic reticulum (ER) is involved in protein folding and ER stress has been implicated in bone mineralization. The role of ER stress in VSMC-mediated calcification is less clear. APPROACH AND RESULTS: mRNA expression of the ER stress markers PERK (PKR (protein kinase RNA)-like ER kinase), ATF (activating transcription factor) 4, ATF6, and Grp78 (glucose-regulated protein, 78 kDa) was detectable in human vessels with levels of PERK decreased in calcified plaques compared to healthy vessels. Protein deposition of Grp78/Grp94 was increased in the matrix of calcified arteries. Induction of ER stress accelerated human primary VSMC-mediated calcification, elevated expression of some osteogenic markers (Runx2 [RUNX family transcription factor 2], OSX [Osterix], ALP [alkaline phosphatse], BSP [bone sialoprotein], and OPG [osteoprotegerin]), and decreased expression of SMC markers. ER stress potentiated extracellular vesicle (EV) release via SMPD3 (sphingomyelin phosphodiesterase 3). EVs from ER stress-treated VSMCs showed increased Grp78 levels and calcification. Electron microscopy confirmed the presence of Grp78/Grp94 in EVs. siRNA (short interfering RNA) knock-down of Grp78 decreased calcification. Warfarin-induced Grp78 and ATF4 expression in rat aortas and VSMCs and increased calcification in an ER stress-dependent manner via increased EV release. CONCLUSIONS: ER stress induces vascular calcification by increasing release of Grp78-loaded EVs. Our results reveal a novel mechanism of action of warfarin, involving increased EV release via the PERK-ATF4 pathway, contributing to calcification. This study is the first to show that warfarin induces ER stress and to link ER stress to cargo loading of EVs.

calcification corresponds with age; among 60-year-olds, ≈60% have VC. 3, 4 VC can be categorized into 2 types: medial and intimal, depending on its localization in the vessel wall. 5 Medial calcification is associated primarily with aging, diabetes, and chronic kidney disease. Intimal calcification predominantly colocalizes with lipid-rich/necrotic regions of atherosclerotic plaques. 6 Vascular smooth muscle cells (VSMCs) play a crucial role in regulating atherosclerotic plaque formation and VC. [7] [8] [9] In response to cellular stress, VSMCs undergo calcification via several mechanisms including apoptosis, 10 release of extracellular vesicles (EVs), 11, 12 loss of calcification inhibitors, 13, 14 aging-related DNA damage, 15 oxidative stress, 16 and osteogenic differentiation. 17 Many of these processes have parallels with physiological bone formation, where chondrocyte apoptosis, downregulation of calcification inhibitors, release of EVs, and expression of bone-specific genes by osteoblasts lead to bone mineralization. 18 The endoplasmic reticulum (ER) is the first organelle of the secretory pathway, where most secreted and transmembrane proteins are folded and mature. ER stress occurs when the influx of unfolded proteins to the ER exceeds its capacity to fold them, resulting in activation of a signaling pathway called the unfolded protein response (UPR). 19, 20 Three ER stress transducers are responsible for sensing an increased load of unfolded proteins and define 3 branches of the UPR: IRE (inositol-requiring protein) 1, ATF (activating transcription factor) 6 , and PERK (PKR [protein kinase RNA]-like ER kinase). 19 Activation of the UPR results in a decrease in protein influx to the ER and expression of various genes encoding chaperones (eg, Grp78 [glucose-regulated protein, 78 kDa] and Grp94) that mitigate the effects of increased load of unfolded proteins. 21, 22 However, if ER stress is overwhelming and cannot be resolved it may lead to cell death. 23 Importantly, ER stress and the UPR have been shown to be crucial for bone development. All 3 branches of the UPR are activated during stages of bone formation to regulate expression of osteogenic genes. [24] [25] [26] [27] [28] Because bone mineralization and VSMC calcification share mechanistic pathways, we hypothesized ER stress might also be involved in regulating pathological VC. Indeed, studies to date suggest that ER stress can accompany VC in mice and rats and increase VSMC osteogenic gene expression and calcification in vitro. [29] [30] [31] [32] [33] [34] [35] [36] [37] However, other key molecular mechanisms involved in VSMC calcification have not been studied. Therefore, we investigated how ER stress influences VC and define a role for this signaling pathway in regulating EV release and cargo loading.

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Human aortic VSMCs were isolated and cultured, as described previously. 38 At passage 3, expression of SM22α (smooth muscle protein 22α), CNN1 (calponin 1), and p-MLC (phosphorylated myosin light chain) was confirmed by immunocytochemistry. Cells were used for experiments at passage 4 to 12. VSMCs were collected from deceased adult organ donors with local ethics committee approval ( 

Eight human carotid arteries and 14 human aortic samples were analyzed. The samples were collected from adult organ transplant donors, characterized, and archived in the laboratory. All human materials were handled in compliance with the Human Tissue Act (2004, United Kingdom) with approval of Cambridge Local Research Ethics Committee (LREC 97/084). Samples of thoracic aorta from wild type male 21 to 28 days old Sprague-Dawley rats from a previously published study. 41 All animal studies were approved by the Ethics Committee for animal experiments of Kings College London, United Kingdom, in compliance with the UK Home Office Guidance on the Operation of the Animals (Scientific Procedures) Act, 1986. Rats were purchased from Charles River Laboratories (United Kingdom) and fed 3 mg warfarin and 1.5 mg vitamin K1 per gram of food (Arie Blok diets, 4165.00) for 1 week or 4 weeks (rats used for immunohistochemistry samples) or 11 days (rats used for Western blotting samples). The control groups consisted of rats fed a normal laboratory diet (PicoLab rodent diet 20). These human and rat tissue samples were fixed in 10% neutral buffered formalin and were then embedded in paraffin wax blocks and cut down in 7-µm thick sections. Immunohistochemistry was performed in serial sections, as described before 42 using VECTASTAIN ABC kit (PK6102; Vector Labs), anti-Grp78, and Grp94 (anti-KDEL, SPA-827, 1:500; Assay Designs) anti-ATF4 (sc-200, 1:250; Santa Cruz) antibodies. Sections were additionally stained for von Kossa and Alizarin Red S to visualize calcification. The stained tissue sections were quantified using scores from 1 to 5 and distributed between nuclear and extracellular expression of Grp 78 and 94 of each vessel. The calcification was scored using grades from 0 to 4 where calcified areas were qualitatively graded; 0: no calcification, 1: <25%, 2: <50%, 3: <75%, and 4: >75%. The collected data from human carotid and aortic samples have been pooled together for statistical analysis.

Analysis of cell death was carried out using the Green FLICA Caspases 3&7 Assay Kit (ImmunoChemistry) according to the manufacturers' protocols, using NucleoCounter NC-3000 (Chemometec). The percentage of healthy, apoptotic, and necrotic cells in each sample was determined based on the scatter plots generated by the NucleoCounter software.

VSMCs were stained with 20 µM DCFDA (2' ,7' -dichlorofluorescein diacetate; Abcam) in phenol red-free DMEM with 0.5% FBS for 1 hour. Afterward, treatments were applied in KRPG (Krebs-Ringer phosphate glucose) buffer (145 mmol/L NaCl, 5.7 mmol/L NaH 2 

Western blotting was performed, as described before. 11 Concentration of protein in samples was measured using DC (detergent compatible) Protein assay (BioRad). The following antibodies were used: Grp78 and Grp94 (anti-KDEL, SPA-827, 1:2500; Assay Designs), GAPDH (sc-25778, 1:5000; Santa Cruz), CNN1 (ab46794, 1:5000; Abcam), SM22α (ab14106, 1:1000; Abcam), p-MLC (36755, 1:500; Cell Signalling), ALP (alkaline phosphatse; ab108337, 1:10 000; Abcam), CD63 (556019, 1:500; BD Bioscience), TSG101 (tumor susceptibility gene 101 protein; T5701, 1:500; Sigma), SERCA2 (sarco/endoplasmic reticulum Ca 2+ -ATPase; 564702, 1:500; Calbiochem) α-actinin-4 (ab108198, 1:500; Abcam), pPERK (ab192591,1:1500; Abcam) anti-mouse (926-32210, 1:10000; Li-Cor and p0447, 1:3000; Dako) and anti-rabbit (926-68071, 1:10000; Li-Cor and 7074S, 1:3000; Cell Signalling). Total protein was quantified in gels using Coomassie Brilliant Blue or Revert (Li-Cor). All blots shown in figures are from the same membrane, cropped for clarity of presentation. Immunocytochemistry was performed as described before, 43 using the following antibodies: Grp78, Santa Cruz, 1:100, total MGP (matrix Gla-protein), VitaK, 1:75, carboxylated MGP, VitaK, 1:75, uncarboxylated MGP, VitaK, 1:250, 44 anti-mousefluorescein isothiocyanate (Dako, F0205, 1:250), anti-rabbit FITC (115-095-068, 1:250; Jackson). Images were taken and signal quantified using the Cytation 3 imaging reader (BioTek).

Dot blots were performed as described before. 45 Briefly, EVs isolated by ultracentrifugation were absorbed onto nitrocellulose membranes, which were blocked with 5% nonfat milk or 3% bovine serum albumin (BSA; TSG101) in PBS in the absence or presence 0.1% (v/v) Tween-20. Antibodies were used as described above.

Quantitative polymerase chain reaction (PCR) was performed as described before 11 with primers listed in the Table. The quality and concentration of RNA were measured using a Nanodrop ND 1000, only samples with a 260/280 ratio above 1.8 were used.

Cells were lysed with 0.1 M HCl. Ca 2+ concentrations were determined colorimetrically using the o-cresolphthalein assay (adapted from Gitelman 46 ) and normalized to protein concentrations. To visualize calcification, VSMCs were fixed and stained with Alizarin Red S (adapted from Bancroft and Stevens 47 ).

ALP activity in cell lysates was determined colorimetrically using pNPP and normalized to protein concentration.

EVs were isolated by differential ultracentrifugation as described before. 11 EVs where isolated from 2 different fractions (2000 g and 100 000 g pellet) and equal amounts of EVs from either fraction were used to study calcification in collagencoated wells. Calcification was quantified using o-cresolphthalein, as described above.

Bead capture assays were performed as described before. 11 Anti-human CD63 antibody was immobilized on beads. VSMC culture media was incubated with anti-CD63-coated. Beads were incubated with anti-CD81-PE (phycoerythrin) antibodies and analyzed by flow cytometry. Arbitrary Units were calculated as mean fluorescence units x percentage of positive beads and normalized to the number of VSMCs.

For immunolabeling, VSMCs were fixed with 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1 M PHEM (60 mM 1,4 piperazine diethylsulfonic acid [PIPES], 25 mM N-2hydroxyethylpiperazine Nl-2-ethanesulfonic acid [HEPES], 10 mM EGTA, and 2 mM MgCl 2 , pH 6.9) buffer followed by washing in PB containing 50 mmol/L glycine, scraped in 1% gelatin, embedded in 12% gelatin, and infused in 2.3 M sucrose. EVs were isolated by ultracentrifugation as described above and pellets were fixed with 2% paraformaldehyde and 0.2% glutaraldehyde in 0.1M PHEM buffer. After washing with PB containing 50 mmol/L glycine, vesicles were embedded in 12% gelatin and infused in 2.3 M sucrose. For both cells and EVs mounted in gelatin, blocks were frozen in liquid nitrogen. Sections were prepared in an ultracryomicrotome (Leica EM Ultracut UC6/FC6, Leica Microsystems), collected with 2% methylcellulose in 2.3 M sucrose, and incubated at room temperature on drops of PBS for 60 minutes at 37 °C, followed by 50 mmol/L gelatin in PBS for 10 minutes and 1% BSA in PBS for 15 minutes at room temperature. Then, cell sections were incubated with anti-Grp78/Grp94 coupled to protein-A 6 nm diameter colloidal gold (1:50, conjugated by Aurion to anti-KDEL, SPA-827; Assay Designs) diluted in 1% BSA in PBS. This was followed by washes with drops of PBS for 10 minutes, and 2 washes with distilled water. Cryosections with EVs were incubated at room temperature on drops of PBS for 60 minutes at 37 °C, followed by 50 mmol/L gelatin in PBS for 10 minutes and 1% BSA in PBS for 15 minutes at room temperature. Then, they were incubated with mouse anti-CD63 (1:5, BD Biosciences, 556019), rabbit anti-TSG101 (1:5, Sigma, T5701) diluted in 1% BSA in PBS for 45 minutes. After 3 washes with drops of PBS for 10 minutes, sections were incubated for 20 minutes in protein-A coupled to 10 nm diameter colloidal gold particles (1:50, CMC Utrecht) diluted in 1% BSA. Sections were fixed with 1% glutaraldehyde in PBS for 5 minutes, followed by 50 mmol/L gelatin in PBS for 10 minutes, and 1% BSA in PBS for 15 minutes. Then, they were incubated with anti-Grp78/Grp94 coupled to protein-A 6 nm diameter colloidal gold (1:50, conjugated by Aurion to anti-KDEL, SPA-827; Assay Designs) diluted in 1% BSA in PBS. This was followed by washes with drops of PBS for 10 minutes, 2 washes of distilled water. Grids were embedded in a thin layer of 1.8% methylcellulose (25 cP) containing 0.4% uranyl acetate. As a control for nonspecific binding of the colloidal gold-conjugated antibody, the primary antibody was omitted. Sections were observed in an Electron Microscope Tecnai T12 Spirit (Thermo Fisher Scientific) equipped with an Eagle 4kx4k CCD (charge-coupled device) camera.

All data represent 3 independent experiments, unless stated otherwise. Data analysis was performed with pooled data from male and female subjects, as we did not have sufficient material for large enough groups to derive a meaningful comparison between the sexes. Graphs show mean+SD with individual data points. Normality of all data was tested using the Shapiro-Wilks test. Variance was tested using the F test alongside a t test and Brown-Forsythe test alongside 1-way ANOVA. Where appropriate t tests, 1-way ANOVA with Tukey or Dunnett post hoc, and 2-way ANOVA with Sidak correction for multiple comparison tests were performed. When the data failed the equal variance or normality tests, the nonparametric Mann-Whitney, 1-sample Wilcoxon and Kruskal-Wallis tests were used, as indicated in figure legends. Statistical analysis was performed in GraphPad Prism 8.2.1. Statistical significance is indicated with asterisks: *P between 0.05 and 0.01, **P between 0.01 and 0.001, ***P<0.001.

We examined ER stress signaling in human arteries by quantitative PCR and immunocytochemistry comparing noncalcified with calcified arteries. The ER stress markers PERK, ATF6, ATF4, CHOP (C/EBP-homologous protein), and Grp78 were all expressed in human carotid and aortic samples. All markers showed a trend towards reduced expression in early disease (fatty streak lesions) and calcified arteries compared with healthy, with the lowest expression in calcified arteries (Table I in the Data Supplement; Figure 1A ). This trend was statistically significant for PERK.

As PCR analysis only gives a snapshot of gene expression at a single time point, we used immunohistochemistry to investigate deposition of downstream ER stress markers Grp78/Grp94 in normal and calcified vessels (carotid and aortic sections from 22 donors, Table II in the Data Supplement; Figure 1B ). Grp78/ Grp94 staining was detectable with 2 distinct localization patterns; either intracellular or deposited in a punctate pattern in the ECM in a pattern similar to previous observations of EVs in the ECM. 43 Although smaller types of vesicles (exosomes) are too small to detect with regular light microscopy, these puncta might represent larger microvesicles or vesicle aggregates, as aggregation has recently been proposed to promote calcification. 48 When Grp78/Grp94 deposition was scored for each section a clear increase in extracellular deposition of Grp78 and Grp94 was observed in donors aged 40 to 60 years, in sections with 75% calcification and in vessels with stages IV to V of atherosclerosis/plaque type (according to American Heart Association classification 49 ; Figure 1C) . These data suggest that calcification of both intima and media coincides with changes in ER stressrelated gene expression and extracellular deposition of ER stress chaperones.

To understand further the relationship between ER stress and VC, VSMCs in vitro were treated with 2 ER stress inducers, tunicamycin and thapsigargin. This resulted in comprehensive activation of all 3 unfolded protein response branches (IRE1, ATF6, PERK, and transcription factors downstream of PERK-ATF4 and CHOP, Figure 2A ) and their target genes Grp78 and Grp94 ( Figure 2B and 2C) .

To examine whether induction of ER stress influenced calcification, VSMCs were treated with calcifying media in the presence of tunicamycin or thapsigargin ( Figure 2D and 2E). This resulted in increased calcification, which could be blocked by the ER stress inhibitor PBA, a chemical chaperone, which inhibits production of Grp78/94, 50 suggesting ER stress can promote calcification.

To examine the mechanisms promoting VSMC calcification in response to ER stress, we first examined the proportion of cells undergoing death ( Figure 3A through 3C). Tunicamycin and thapsigargin alone did not change cell viability; however, calcifying media significantly increased cell necrosis and this was significantly decreased by tunicamycin and thapsigargin. In the presence of Ca and P, tunicamycin did not increase apoptosis and cell death rates were the same in pairs of samples treated or not with ER stress pathway modifiers suggesting increased calcification in response to ER stress could not be attributed to increased apoptosis.

Drawing on the similarities between bone formation and VSMC calcification, we examined whether ER stress is involved in regulating expression of osteo/ whereas some showed different responses to tunicamycin and thapsigargin (Runx2 [RUNX family transcription factor 2], OPG [osteoprotegerin]; Figure IA in the Data Supplement). As ALP was consistently upregulated and is an early indicator of osteogenic differentiation, we examined its protein expression and activity. Both tunicamycin and thapsigargin increased protein expression, however, this did not translate into higher activity levels, and the induction could not be blocked by PBA. Taken together, these data suggest ER stress does not induce calcification via regulation of osteogenic processes ( Figure 3E -regulated protein, 78 kDa) . A, Quantification of EV release using a bead capture assay. VSMCs were treated 0.01 to 0.1 µg/mL tunicamycin (TM) or 0.01 to 0.1 µg/mL thapsigargin (TG) for 24 h in M199 with 0.5% FBS. Statistical significance was tested with ANOVA. B, SMPD3 (sphingomyelin phosphodiesterase 3) mRNA expression measured by real-time polymerase chain reaction. VSMCs were treated 0.1 µg/mL TM or 0.1 µg/mL TG for 24 h. Statistical significance was tested with 1-sample t tests. C, SMPD3 inhibitor spiroepoxide blocks ER stress-enhanced VSMC calcification. (Continued ) However, examination of contractile protein expression showed that ER stress decreased SMC-specific contractile markers SM22α, SMTN (smoothelin), CNN1, and p-MLC ( Figure 3F through 3H) , indicative of VSMC phenotypic modulation to a synthetic phenotype. This is in line with a recent study showing a negative correlation between ER stress signaling and myocardin-driven phenotype regulation. 51 

Phenotypic modulation of VSMCs has been linked to the induction of EV release, an early event in calcification. 11,52-54 Moreover, we previously reported the presence of ER-resident proteins in VSMC-derived EVs including chaperones (Hsp70 [heat shock protein, 70 kDa], Grp94, Grp78), and the punctate extracellular pattern of Grp78 deposition in calcified arteries was consistent with vesicle-mediated calcification. 43 Therefore, we tested the effect of ER stress on VSMC EV release and cargo loading. Both tunicamycin and thapsigargin increased EV release up to 5-fold ( Figure 4A ), and this was accompanied by increased expression of SMPD3 ( Figure 4B ), a key regulator of EV release. Importantly, the SMPD3 inhibitor spiroepoxide blocked ER stressenhanced VSMC calcification, suggesting EVs were mediating ER stress-induced calcification ( Figure 4C ).

To assess whether EVs released in response to ER stress have increased calcification capacity, we performed in vitro calcification assays. The 100 000 g pellets of EVs (enriched for exosomes 11 ) isolated from cells treated with tunicamycin and control cells were placed in collagen-coated wells in the presence of calcifying media. We found that EVs from tunicamycintreated cells had a higher propensity to calcify compared with EVs from vehicle-treated cells ( Figure 4D ; Figure IIA through IIC in the Data Supplement). We also observed that PBA, which decreased calcification, also decreased Grp78 expression in VSMCs ( Figure 4E and 4F). This suggested that Grp78, which was previously shown to nucleate mineral, 55 could be responsible for the increased calcification capacity of EVs. Indeed, western blot showed that Gpr78 loading into both the 2000 g and 100 000 g pellets of EVs (apoptotic bodies and exosomes, respectively) was increased in response to ER stress ( Figure 4G and 4H, Figure IID through IIF in the Data Supplement). Grp94 loading to EVs was also increased but not significantly.

Electron microscopy confirmed the specificity of Grp78/Grp94 loading into TSG101-and CD63-positive EVs from the 100 000 g pellet ( Figure 4I ). We found Grp78/Grp94 in small vesicles (consistent with exosomes, 20-100 nm) but predominantly in larger vesicles (microvesicles, 200-1000 nm). Of note, not all EVs were positive for TSG101, CD63, or Grp78/ Grp94, which reflects their heterogeneity ( Figure  IIIA in the Data Supplement). Electron microscopy of VSMCs stained for Grp78/Grp94 shows that additional to the expected ER staining, Grp78/Grp94 were also present in multivesicular bodies, further supporting specific loading of the chaperones into EVs (Figure IIIA in the Data Supplement). Dot blot analysis of EVs with and without lysis suggested that Grp78/ Grp94 are present both inside and on the surface of EVs, with possibly a larger amount on the surface ( Figure 4J ). As expected, we found more TSG101 inside EVs than on the surface, and no difference in CD63. To confirm a role for Grp78 in calcification, we used siRNA to knock-down Grp78 which resulted in decreased calcification of VSMCs ( Figure 4K , Figure  IIIB in the Data Supplement).

Warfarin is known to be a potent inducer of calcification, as it inhibits γ-carboxylation of calcification inhibitors, 56 which occurs within the ER. Therefore, we next tested whether warfarin could induce ER stress. We treated human primary VSMCs with warfarin and found that ATF4 mRNA was upregulated in response Statistical significance was tested with 1-sample t test. E and F, Western blot and quantification, showing that 4-phenylbutyric acid (PBA), which decreases ER stress-induced calcification, decreases Grp78 (glucose-regulated protein, 78 kDa) expression in VSMCs. VSMCs were treated with 0.1 µg/mL TM and 1 mmol/L PBA for 24 h. Statistical significance was tested with ANOVA. G and H, Western blot showing Grp78 is increased in EVs released from cells treated with ER stress inducers. VSMCs were treated with 0.2 µg/mL TM or TG in phenol red-free DMEM with 0.1% bovine serum albumin (FBS free); EVs were isolated from culture media by ultracentrifugation. Statistical significance was tested with 1-sample t tests. I, EVs were isolated by ultracentrifugation (100 000g), immunogold staining, and electron microscopy was carried out on sections of fixed EV pellets. Grp78/ Grp94 (6 nm gold) are localized in EVs of various sizes expressing CD63 and TSG101 (tumor susceptibility gene 101 protein; both 10 nm gold). Scale bars are 100 nm. J, Dot blot showing Grp78/Grp94 is detected predominantly on the surface of EVs (samples without detergent). TSG101 and CD63 were used as positive and negative control, respectively. EVs were isolated by ultracentrifugation from primary VSMCs culture supernatants. Representative blots from n=3 experiments. K, siRNA (short interfering RNA) knock-down of Grp78 decreases calcification of VSMCs treated with 2.7 mmol/L Ca 2+ and 2.5 mmol/L PO 4 3for 18 h. Cells were treated with Grp78 siRNA or control siRNA 24 h before applying calcification media. Calcification was quantified with o-cresolphthalein assay. Statistical significance was tested with t test. All graphs show mean+SD and individual data points. AU indicates arbitrary units; and CTRL, control. Dots denote individual data points, *P<0.05, **P<0.01, ***P<0.001.

( Figure 5A ). Western blot showed increased Grp78 but not Grp94 expression in response to warfarin ( Figure 5B and 5C) , as well as a transient increase in PERK phosphorylation ( Figure 5D and 5E, Figure IVA in the Data Supplement). However, we observed no consistent increase of Grp78 loading into EVs ( Figure  IVB and IVC in the Data Supplement). Treating cells with PBA blocked warfarin-induced calcification of VSMCs cultured in calcifying conditions ( Figure 5F ).

As we ruled out effects of warfarin on oxidative stress ( Figure V in the Data Supplement), these data suggest ER stress mediates in part the procalcific effects of warfarin.

Next, we measured EV release in warfarin-treated VSMCs and its regulation by ER stress signaling. Warfarin increased EV release by VSMCs, and this was blocked by a PERK inhibitor, which acts upstream of ATF4 ( Figure 5G ). The PERK inhibitor also blocked the warfarin-induced increase in Grp78 expression ( Figure 5H through 5J) . In contrast, an IRE1 inhibitor had no effect on EV release or Grp78 levels (Figure 5H through 5J, Figure VI in the Data Supplement) suggesting specific involvement of the PERK-ATF4 ER stress pathway.

Next, we set out to assess by immunohistochemistry whether ER stress was induced in an animal model of warfarin-induced medial VC ( Figure 6A ). Aortas from control rats showed no calcification, expressed Grp78/ Grp94 which showed an intracellular localization, and showed no ATF4 staining. Rats treated with warfarin for 1 week showed no calcification but had increased Grp78/Grp94 and markedly elevated nuclear ATF4 expression. At this stage, some deposition of Grp78/ Grp94 in the ECM was also observed. After 4 weeks of warfarin treatment, aortas were calcified and rounded puncta of Grp78/Grp94 in the ECM were clearly apparent, with reduced intracellular staining at sites of calcification. Increased expression of Grp78/Grp94 and ATF4 was observed in calcified areas and increased expression of Grp78 (and not Grp94) in aortas of rats treated with warfarin was confirmed by Western blotting (Figure 6B and 6C) .

Since we show that warfarin induces ER-mediated changes that lead to VSMC calcification, we also investigated whether ER stress mediates the well-known γcarboxylation inhibiting effects of warfarin. Expression of total, carboxylated, and uncarboxylated MGP was measured in response to ER stress ( Figure VII in the Data Supplement), and no changes were observed. This suggests that disruption of ER function does not translate into decreased protein carboxylation.

This study is the first to comprehensively examine expression of ER stress markers in human vascular tissue. We observed that mRNA expression of ER stress markers was decreased in fatty streak and calcified human aortic samples compared with healthy, suggesting there is dysregulation of homeostatic ER stress signaling during disease development. We also observed increased extracellular deposition of Grp78 and Grp94 at sites of calcification, consistent with the presence of Grp78 in EVs and its role in promoting calcification. To the best of our knowledge, only one other study has examined the expression of ER stress markers in human arteries 57 showing upregulation of Grp78 and Grp94 in vessels from aneurysm patients supporting our conclusion that vascular disease is associated with changes in ER stress signaling components.

We demonstrated that ER stress can be induced in human primary VSMCs in vitro by tunicamycin and thapsigargin and that all 3 branches of the UPR were activated. 30, 31, 35 We also showed that the addition of ER stress inducers enhanced VSMC calcification, but consistent with previous studies in rodent models, tunicamycin, and thapsigargin alone did not induce calcification. 30, 32, 33, 36, 37 ER stress-mediated apoptosis has been reported in some models of VC 30,34-36 ; however, it was not involved in ER stress-enhanced calcification in response to elevated calcium and phosphate. On the contrary, thapsigargin decreased the rate of apoptosis and both tunicamycin and thapsigargin protected VSMCs from necrosis. These findings may be due to differences between in vivo and in vitro models or different ER stress inducers and suggests that ER stress can mediate both prosurvival and procalcification signaling, depending on the patho/physiological context. Indeed, several reports showed a protective role for ER stress in vascular disease, and this is consistent with the reduction in ER stress signaling we observed in diseased tissue samples. [58] [59] [60] 

Tunicamycin and thapsigargin treatments changed expression of almost all examined osteo/chondrogenic genes in VSMCs causing decreased as well as increased expression. However, ALP activity was not increased by ER stress despite increased mRNA and protein levels with activation required to form a functional enzyme. 61 This finding is in contrast to osteo/chondrogenic differentiation in bone, where these proteins are expressed in a concerted manner, with many directly regulated by ER stress signaling. 18, 62 The apparently chaotic pattern of osteogenic gene expression observed in VSMCs in response to ER stress may reflect activation via aberrant signals and their expression is unlikely to play a role in the accelerated calcification observed in response to ER stress. This is in line with literature showing that osteogenic differentiation might not be the primary mechanism of calcification in all contexts. 63 In contrast to osteogenic gene expression, VSMC contractile marker expression was uniformly downregulated by tunicamycin and thapsigargin treatments (SM22α and SMTN mRNA and p-MLC protein) supporting the notion that ER stress promotes de-differentiation of VSMCs to a synthetic phenotype. 30 

In our study, we focused on EVs isolated in the 2000 g and 100 000 g pellets, which correspond to apoptotic bodies and exosomes, respectively, as both were previously implicated in mediating calcification. 11, 38 We identified a novel role for ER stress in mediating increased EV release by VSMCs consistent with their transition to a synthetic phenotype (loss of contractile markers and increased SMPD3 expression). Our study confirms a link between EV release and ER stress, which was reported in other cell types 64 and in VSMCs subjected to mechanical stress. 65 Importantly, ER stress was also associated with increased levels of Grp78 in EVs. Grp78 has been shown to function on the cell surface in other cell types 66 and to facilitate calcium phosphate crystal formation on a collagen matrix, due to its presence on the surface of osteoblasts. 55, 67 Our results suggest that it elicits the same effect when loaded into EVs. Because we did not observe Grp78 expression on the surface of VSMCs (data not shown), its procalcification properties demonstrated in the siRNA knock-down experiment are most likely due to it being secreted into the ECM and this is consistent with increased extracellular deposition of Grp78/Grp94 in calcified human arteries.

To exclude the possibility that Grp78 co-isolates with EVs during isolation by differential ultracentrifugation, 68 we performed electron microscopy, which unequivocally shows Grp78/Grp94 staining associated with EVs and MVBs. Additionally, online EV database EVpedia 69 lists 608 studies (on April 11, 2019), which identified Grp78 in EV samples derived from human material, confirming that this protein is indeed specifically loaded into vesicles.

In many experiments, we observed upregulation of Grp94 expression in response to ER stress induced by tunicamycin or thapsigargin and warfarin, alongside Grp78. We also found increased Grp94 loading into EVs of cells treated with ER stress but less consistent than for Grp78. However, we cannot exclude the possibility that some of the effects of ER stress that we observed were due to increased Grp94 expression, whose mineralization-promoting properties are unknown. Grp78 is hypothesized to nucleate mineralization via calcium and collagen I binding. 55 Although Grp94 is also a calciumbinding protein 70 found in mineralizing EVs, 71 its ECM protein-binding capabilities have not been investigated.

Warfarin is an oral anticoagulant commonly administered to patients that suffer from hypercoagulability. 72 Warfarin inhibits VKORC1 (vitamin K epoxide reductase complex subunit 1) thereby diminishing available vitamin K, which is a required cofactor for protein carboxylation. 73 Warfarin promotes VC as it inhibits carboxylation of the endogenous calcification inhibitor MGP. 13 The link between warfarin and ER stress has not been examined before, even though it is known that protein carboxylation occurs within the ER. 74 We show here that warfarin induces expression of Grp78, Grp94, and ATF4 in rat aortas and in human VSMCs in vitro. Additionally, warfarin increased VSMC calcification in vitro in an ER stress-dependent manner. We found that warfarin-induced EV release, an effect mediated by the PERK-ATF4 branch of the UPR. However, increased Grp78 loading into EVs was not observed as a result of warfarin treatment most likely due to warfarin acting specifically via the PERK-ATF4 branch of the UPR and only having a modest effect on upregulation of Grp78, in contrast to tunicamycin/thapsigargin, which strongly induce all 3 branches. Additionally, it is possible that the short time point of our in vitro experiments did not allow for sufficient Grp78 accumulation in EVs in vitro. However, the punctate pattern of Grp78/Grp94 staining in warfarin-fed rat aortas is consistent with Grp78 accumulation in EVs.

We provide evidence that ER stress-mediated EV release and Grp78 deposition in the ECM promote calcification ( Figure 7) . We show that ER stress induces changes in osteogenic gene expression and contractile VSMC phenotype loss. Both of these are known to be associated with increased EV release, and our results provide further evidence that ER stress is involved. We also show that warfarin induces the PERK-ATF4 branch of the UPR, which has previously been implicated in VC, and via this pathway increases EV release and VSMC calcification. This study is the first, to our knowledge, to show that warfarin induces ER stress and to link ER stress to cargo loading of EVs.

The next important steps would be investigating the molecular events that lead from ER stress activation to increased EV release and Grp78 loading into EVs. Because inhibiting ER stress has been recently described to attenuate VC in animal models, 75-77 ER stress pathways might represent a new therapeutic possibility.

Mechanisms of vascular calcification in CKD-evidence for premature ageing?

The mechanism of vascular calcification -a systematic review

Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag

Regulatory mechanisms in vascular calcification

Biology of calcification in vascular cells: intima versus media

Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study

Vascular calcification

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate

Mechanistic insights into vascular calcification in CKD

Apoptosis regulates human vascular calcification: In vitro evidence for initiation of vascular calcification by apoptotic bodies

Vascular smooth muscle cell calcification is mediated by regulated exosome secretion

Discoidin domain receptor-1 regulates calcific extracellular vesicle release in vascular smooth muscle cell fibrocalcific response via transforming growth factor-β signaling

Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization

Cloning and targeted deletion of the mouse fetuin gene

Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells

Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling

Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cellmediated vascular calcification

Genetic control of bone formation

The unfolded protein response: from stress pathway to homeostatic regulation

Signal integration in the endoplasmic reticulum unfolded protein response

Induction of Grp78/ BiP by translational block: activation of the Grp78 promoter by ATF4 through and upstream ATF/CRE site independent of the endoplasmic reticulum stress elements

The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins

ER stress-induced cell death mechanisms

In situ hybridization studies suggest a role for the basic region-leucine zipper protein hXBP-1 in exocrine gland and skeletal development during mouse embryogenesis

The IRE1α-XBP1 pathway is essential for osteoblast differentiation through promoting transcription of Osterix

IRE1α dissociates with BiP and inhibits ER stress-mediated apoptosis in cartilage development

The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system

postnatal growth, and the function and viability of the pancreas

ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome

Endoplasmic reticulum stress-mediated apoptosis is activated in vascular calcification

Activating transcription factor 4 is involved in endoplasmic reticulum stress-mediated apoptosis contributing to vascular calcification

Bone morphogenetic protein-2 activates nadph oxidase to increase endoplasmic reticulum stress and human coronary artery smooth muscle cell calcification

Activating transcription factor 4 regulates stearate-induced vascular calcification

PERK-eIF2α-ATF4-CHOP signaling contributes to TNFα-induced vascular calcification

Endoplasmic reticulum stress effector CCAAT/enhancer-binding protein homologous protein (CHOP) regulates chronic kidney diseaseinduced vascular calcification

Saturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity

Activating transcription factor-4 promotes mineralization in vascular smooth muscle cells

Endoplasmic reticulum stress in arterial smooth muscle cells: a novel regulator of vascular disease

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD

The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule

Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)

Technetium-99m and rhenium-188 complexes with one and two pendant bisphosphonate groups for imaging arterial calcification

Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis

Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization

Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification

Exosome secretion promotes chemotaxis of cancer cells

An improved automated procedure for the determination of calcium in biological specimens

Theory and Practice of Histological Techniques

Roles and regulation of extracellular vesicles in cardiovascular mineral metabolism

Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging

Influence of molecular and chemical chaperones on protein folding

Antagonistic relationship between the unfolded protein response and myocardin-driven transcription in smooth muscle

Reactive oxygen-forming Nox5 links vascular smooth muscle cell phenotypic switching and extracellular vesicle-mediated vascular calcification

Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques

Sortilin mediates vascular calcification via its recruitment into extracellular vesicles

Stress chaperone GRP-78 functions in mineralized matrix formation

Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification

Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress

Protective role of Gipie, a Girdin family protein, in endoplasmic reticulum stress responses in endothelial cells

Mono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated with increased C/EBP homologous protein expression

New endoplasmic reticulum stress regulator, Gipie, regulates the survival of vascular smooth muscle cells and the neointima formation after vascular injury

Tissue nonspecific alkaline phosphatase is activated via a two-step mechanism by zinc transport complexes in the early secretory pathway

Transcriptional mechanisms in osteoblast differentiation and bone formation

Breast arterial calcification in chronic kidney disease: absence of smooth muscle apoptosis and osteogenic transdifferentiation

Multivesicular body formation enhancement and exosome release during endoplasmic reticulum stress

Er-stress-dependent microparticles derived from smooth muscle cells promote endothelial dysfunction during thoracic aortic aneurysm and dissection

Cell surface expression of 78-kDa glucoseregulated protein (GRP78) mediates diabetic nephropathy

Expression and distribution of grp-78/bip in mineralizing tissues and mesenchymal cells

Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles

EVpedia: a community web portal for extracellular vesicles research

The peptide-binding activity of GRP94 is regulated by calcium

Label-free quantification proteomics reveals novel calcium binding proteins in matrix vesicles isolated from mineralizing Saos-2 cells

New insights into the pros and cons of the clinical use of vitamin K antagonists (VKAs) versus direct oral anticoagulants (DOACs)

Vitamin k-dependent proteins, warfarin, and vascular calcification

Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate/protein kinase A pathway

Selenium suppresses oxidative-stress-enhanced vascular smooth muscle cell calcification by inhibiting the activation of the PI3K/AKT and ERK signaling pathways and endoplasmic reticulum stress

Globular adiponectin reduces vascular calcification via inhibition of ER-stress-mediated smooth muscle cell apoptosis

We would like to thank Dr Carmen López-Iglesias, Dr Kèvin Knoops, Willine van de Wetering, and Hans Duimel from the Microscopy Core Lab at Maastricht University for support with electron microscopy. 

None.